Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants

Stephane P Hays1, E O'Brian Smith, Agneta L Sunehag

  • 1USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, 1100 Bates St, Houston, TX 77030, USA.

Pediatrics
|November 3, 2006
PubMed

Insights

Hyperglycemia is common in extremely low birth-weight infants and increases risks for death, severe brain bleeds, and longer hospital stays. Managing blood glucose may improve outcomes for these vulnerable infants.

Area of Science:

  • Neonatalogy
  • Pediatric Endocrinology
  • Clinical Research

Background:

  • Extremely low birth-weight (ELBW) infants often experience metabolic disturbances.
  • Hyperglycemia is a frequent complication in parenterally fed ELBW infants.
  • The impact of hyperglycemia on adverse outcomes in ELBW infants requires further elucidation.

Purpose of the Study:

  • To determine the prevalence of hyperglycemia in ELBW infants.
  • To investigate if hyperglycemia elevates the risk of early adverse outcomes (death or severe intraventricular hemorrhage).
  • To assess the effect of hyperglycemia on hospital stay duration in survivors without severe intraventricular hemorrhage.

Main Methods:

  • Retrospective chart review of 93 ELBW infants admitted in 2001.
  • Averaged key physiological parameters (blood glucose, dopamine, oxygen, sodium) during the first week of life or until adverse events.
  • Calculated time ratio for blood glucose >150 mg/dL in survivors without severe intraventricular hemorrhage.

Main Results:

  • Over 50% of ELBW infants exhibited persistent hyperglycemia (>150 mg/dL) in the first week.
  • Higher average blood glucose concentrations correlated with adverse outcomes, interacting with Clinical Risk Index for Babies score and inspired oxygen levels.
  • Increased hospital stay duration was linked to hyperglycemia duration, interacting with birth weight and inspired oxygen levels.

Conclusions:

  • Confirms high prevalence of hyperglycemia in parenterally fed ELBW infants.
  • Elevated blood glucose levels are associated with increased risk of early mortality, severe intraventricular hemorrhage, and prolonged hospitalization.
  • Suggests that hyperglycemia prevention and management could significantly improve outcomes for ELBW infants.
Abstract

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...